← Back to Vaccine Database

QazCovid-in

Inactivated vaccine · VDDBV0618

Target & Classification

SARS-CoV-2SARS-CoV-2
Inactivated vaccine
Covid19; Severe Acute Respiratory Syndrome
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT04530357 Phase 2Covid19; Severe Acute Respiratory Syndrome
NCT04691908 Phase 3Covid19; Severe Acute Respiratory Syndrome